News Conference News AHA 2024 Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360 Michael O'Riordan November 18, 2024
News Daily News High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low Michael O'Riordan November 13, 2024
News Conference News TCT 2024 Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick Yael L. Maxwell November 07, 2024
News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
Presentation TCT 2024 TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System Presenter: Daniel Spoon October 30, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
Presentation TCT 2024 The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association) Presenter: Brian Lindman October 30, 2024
Presentation TCT 2024 TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis Presenter: Daniel Mitchell October 30, 2024
Presentation TCT 2024 TCT 854: Physiologic Response of Normal Aortic Valves During Dobutamine Stress Presenter: Rob Eerdekens October 30, 2024
Presentation TCT 2024 TCT 655: Hemodynamic Effects of Aortic Banding to Simulate Progressive Aortic Stenosis Presenter: Rob Eerdekens October 30, 2024
Presentation TCT 2024 TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis Presenter: Philippe Genereux October 30, 2024
Presentation TCT 2024 TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis Presenter: Philippe Genereux October 30, 2024
Presentation TCT 2024 TCT 650: Independent Predictors of 2-Year Mortality in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement Presenter: Vincent Lipari October 30, 2024
Presentation TCT 2024 TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis Presenter: Mohammad Reza Movahed October 30, 2024
Presentation TCT 2024 TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement Presenter: Constantijn Venema October 30, 2024
Presentation TCT 2024 TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR Presenter: Rishi Sukhija October 30, 2024
Presentation TCT 2024 TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study Presenter: Rupak Banerjee October 30, 2024
Presentation TCT 2024 TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades Presenter: Zaid Abdulelah October 30, 2024
Presentation TCT 2024 The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes Presenter: David Wood October 30, 2024